Andrew Intlekofer
, Lab Program Director · New York Presbyterian Hospital
Credentials: · · · · ·
History
Present- Present
Lab · MSK


- 2011–2012
Memorial Sloan Kettering
Research
Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin
Nature Immunology · 2005 · First of 18 authors · 1,050 citations
Asymmetric T lymphocyte division in the initiation of adaptive immune responses
Science · 2007 · 676 citations
Hypoxia Induces Production of L-2-Hydroxyglutarate
Cell Metabolism · 2015 · First of 11 authors · 431 citations
- SH
15 papers
- AZ
13 papers
- AK
13 papers
- AN
13 papers
- AD
12 papers
- AM
12 papers
- GS
12 papers
- LF
12 papers · 1 as a fellow
Grants
- 2024–2029
Targeting Isocitrate Dehydrogenase Mutations by Enzyme Hyperactivation
National Cancer Institute · R01
Contact PI · $1.4M · Sloan-Kettering Inst Can Research
- 2020–2027
Metabolic Control of Normal and Malignant Hematopoiesis
National Cancer Institute · R37
Contact PI · $3.4M · Sloan-Kettering Inst Can Research
- 2016–2021
Investigating L-2-Hydroxyglutarate in Normal Hematopoiesis and Leukemogenesis
National Cancer Institute · K08
Contact PI · $886.7K · Sloan-Kettering Inst Can Research

